1. Home
  2. WNS vs AMRX Comparison

WNS vs AMRX Comparison

Compare WNS & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WNS
  • AMRX
  • Stock Information
  • Founded
  • WNS 1996
  • AMRX 2002
  • Country
  • WNS India
  • AMRX United States
  • Employees
  • WNS N/A
  • AMRX N/A
  • Industry
  • WNS Business Services
  • AMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • WNS Consumer Discretionary
  • AMRX Health Care
  • Exchange
  • WNS Nasdaq
  • AMRX Nasdaq
  • Market Cap
  • WNS 2.5B
  • AMRX 2.5B
  • IPO Year
  • WNS N/A
  • AMRX N/A
  • Fundamental
  • Price
  • WNS $74.74
  • AMRX $8.44
  • Analyst Decision
  • WNS Buy
  • AMRX Strong Buy
  • Analyst Count
  • WNS 8
  • AMRX 4
  • Target Price
  • WNS $63.00
  • AMRX $11.50
  • AVG Volume (30 Days)
  • WNS 1.9M
  • AMRX 1.8M
  • Earning Date
  • WNS 07-17-2025
  • AMRX 08-08-2025
  • Dividend Yield
  • WNS N/A
  • AMRX N/A
  • EPS Growth
  • WNS 24.08
  • AMRX N/A
  • EPS
  • WNS 3.71
  • AMRX N/A
  • Revenue
  • WNS $1,314,942,000.00
  • AMRX $2,830,186,000.00
  • Revenue This Year
  • WNS $5.56
  • AMRX $9.84
  • Revenue Next Year
  • WNS $9.37
  • AMRX $7.33
  • P/E Ratio
  • WNS $17.62
  • AMRX N/A
  • Revenue Growth
  • WNS N/A
  • AMRX 13.42
  • 52 Week Low
  • WNS $42.62
  • AMRX $6.50
  • 52 Week High
  • WNS $74.84
  • AMRX $9.48
  • Technical
  • Relative Strength Index (RSI)
  • WNS 81.75
  • AMRX 66.90
  • Support Level
  • WNS $56.23
  • AMRX $8.05
  • Resistance Level
  • WNS $59.07
  • AMRX $8.47
  • Average True Range (ATR)
  • WNS 2.32
  • AMRX 0.21
  • MACD
  • WNS 1.39
  • AMRX 0.04
  • Stochastic Oscillator
  • WNS 99.31
  • AMRX 96.77

About WNS WNS (Holdings) Limited Sponsored ADR (Jersey)

WNS (Holdings) Ltd is a provider of business process management (BPM) services, offering comprehensive data, voice, analytical, and business transformation services with a blended onshore, nearshore and offshore delivery model. The company's segment includes Banking/Financial Services, and Insurance; Travel, Shipping/Logistics, and Utilities; Manufacturing/Retail/Consumer, Hi-tech/Professional Services, and Procurement; Healthcare/Life Sciences. Geographically, the company generates the majority of its revenue from North America (primarily the US), followed by the UK. The company also has a presence in Australia, Europe (excluding the UK), South Africa, and other countries.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: